Patients with no nail damage before starting the study
ECOG performance \< 2
Ability to provide written informed consent
You may not be if
Patient allergic to any of the treatment components
Use of film-forming solution, solvents or any other products applied to the fingernails (artificial nails ...) in three weeks before the first of docetaxel treatment
Risk of exposure to aggressive factors nail during the study
Using refrigerants gloves during chemotherapy treatments
Onychophagia
Presence of nail disease or a history of nail pathology (infectious and other)
Pregnant or breast feeding females
Patients whose condition is not compatible with the follow-up study
Clareo Health | Efficacy of Evonail® Solution in the Prevention of Nail Damage Induced by Docetaxel in Patients With Breast Cancer.
